GE Healthcare, a subsidiary of General Electric, is betting big on the rapid growth of China's healthcare market... READ MORE›
Women have been exposed to unnecessary harm due to poor regulation for vaginal mesh products, medical experts have warned... READ MORE›
Prof John Hardy, a neuroscientist at UCL who first proposed that amyloid proteins play a central role in Alzheimer's disease, welcomed the results... READ MORE›
Between 2005 and 2007 Gottlieb was FDA deputy commissioner for medical and scientific affairs... READ MORE›
Deaths or serious adverse reactions during Phase 1 clinical trials are rare... READ MORE›
How pharmaceutical company Alexion set the price of the world's most expensive drug... READ MORE›
The study was a Phase I clinical trial, in which healthy volunteers take the medication to evaluate the safety of its use, the ministry said... READ MORE›
Poor African women are chosen because they are the high-risk group... READ MORE›
The results, based on 2,000 patients with mild dementia, are a significant blow because there are currently no treatments to slow the effects of Alzheimer's... READ MORE›
Pamplona will pay 88.10 per share in cash for Parexel, representing a 5 percent premium to the stock's Monday close... READ MORE›
For women with high risk of nausea and vomiting in pregnancy, the society recommends vitamin B6 or Diclectin... READ MORE›
Experimental vaccine has shown to be 100 percent effective in preventing spread of Ebola when tested on animals... READ MORE›
The company said the deal would create leading oncology expertise, leveraging Covance's extensive experience in late-stage studies with Chiltern's early-stage development offerings... READ MORE›
After a while, the tooth will start to rebuild itself, and the sponge will disintegrate, according to the scientists... READ MORE›
Mers ebola bird flu science's big missed opportunities... READ MORE›
WASHINGTON President Barack Obama has nominated Dr. Robert Califf a leading cardiologist and researcher as the next commissioner of the U.S... READ MORE›
Mitsubishi Tanabe Pharma will pay 39 for each Neuroderm share, a premium of about 17 percent to its Friday close... READ MORE›
A man left brain-dead after an experimental drug trial in France has died, local media report... READ MORE›
French clinical trial goes wrong and hospitalises test subjects... READ MORE›
InVentiv, which is equally owned by private equity firms Advent International and Thomas H. Lee Partners, works with larger firms, including the top 20 biopharmaceutical companies... READ MORE›
Donald Langevoort, a professor at the Georgetown University Law Center, said the Alzheimer's Association's wide access to embargoed materials raises lots of red flags... READ MORE›
Europe has strict regulations governing the conduct of clinical trials, with Phase I tests subject to particular scrutiny... READ MORE›
Clinical trials of three new Ebola treatments are due to start next month in West Africa, MA C decins Sans FrontiA?res has announced... READ MORE›
Perhaps that's why Sarepta's executives have claimed in statements that the average price for Exondys 51 is 300,000 per patient per year... READ MORE›
At Queens Hospital's Cancer Center in New York, researchers are trying to reach disadvantaged patients by bringing clinical trials to them... READ MORE›
An American health care worker who contracted Ebola while volunteering in a Sierra Leone treatment unit has been downgraded to critical condition at the Na... READ MORE›
Mr Kostoglou was cured of hepatitis C last year, after being treated in a clinical trial of the direct-acting anti-viral medicine, Zepatier... READ MORE›
A spokesman for the Department of Health and Human Services, which oversees the FDA, said it had made addressing the opioid crisis a top priority... READ MORE›
French Health Minister Marisol Touraine and Gilles Hedan, professor of clinical neurology, attend a news conference in Rennes, France, Jan 15, 2016... READ MORE›
French health authorities have said three of the hospitalized volunteers face possible brain damage... READ MORE›
One, called bapineuzumab, also looked promising in the early clinical trials but flopped when it reached Phase 3 trials, which test the drug on larger populations... READ MORE›
The trial involved 90 healthy volunteers who were given the experimental drug in varying doses at different times, she told reporters at a news conference in Rennes... READ MORE›
Daily Digital News provides public access to an archive of historical news articles from many popular news sources. Daily Digital News provides keyword searchable summaries, and links, to news articles that were originally publically accessible, and all news articles presented on dailydigitalnews.com were initially freely available to the general public. Daily Digital News does not claim any copyright ownership of the aggregated content of this website. Aggregated news content presented on dailydigitalnews.com may be subject to copyright, and the use made here is consistent with the principles of limited use for research and education. Daily Digital News takes advantage of unique web-crawling technologies and algorithms. This includes the use of services provided by Alchemy API (by IBM Watson) as well as other open source technologies. Daily Digital News operates this website on a not for profit basis. No income, revenue, remuneration, or profit of any kind has been made as a result of providing this website to the public. Use of this website is at the user's own discretion. Daily Digital News exercises no control over the use made of this website and accepts no liability to users or resources in relation to the contents of, or use of, or otherwise in connection with this website. Full Terms & Conditions